A
Azura Ophthalmics Limited
Profile managed by Bizz IdAzura Ophthalmics
Israel
11-50 employees
2014
Description
Clinical-stage Israeli biotech company, founded in 2014. Develops ophthalmic keratolytics for meibomian gland dysfunction and evaporative dry eye. AZR-MD-001 in Phase 3 trial. Funded by OrbiMed and TPG ($37.2M raised).